{"id":10160,"date":"2020-12-02T22:06:38","date_gmt":"2020-12-02T13:06:38","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=10160"},"modified":"2025-08-25T10:34:42","modified_gmt":"2025-08-25T01:34:42","slug":"diseaselist_7","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/patient_specific_ips\/diseaselist_7","title":{"rendered":"Respiratory tract diseases, Eye diseases"},"content":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n\uff0a In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

*Terms:
\nIn relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary.
\nIn relation to all iPS cell lines, commercial use is prohibited.
\nIn relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize.<\/p>\n

Update : 2020.11.27<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Name of diseases<\/th>\nPatient No.<\/th>\n*Terms<\/th>\nApproval For<\/th>\n>HPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReferences<\/th>\n<\/tr>\n
Respiratory tract diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Sarcoidosis<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Sarcoidosis<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1496<\/td>\nHPS1497<\/td>\nHPS1498<\/td>\nHPS1499<\/td>\nHPS1500<\/td>\nHPS1501<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2090<\/td>\nHPS2091<\/td>\nHPS2092<\/td>\nHPS2093<\/td>\nHPS2094<\/td>\nHPS2095<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Idiopathic interstitial pneumonia<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1324<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1466<\/a><\/td>\nHPS1467<\/td>\nHPS1468<\/td>\nHPS1469<\/td>\nHPS1470<\/td>\nHPS1471<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>3<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3143<\/a><\/td>\nHPS3144<\/td>\nHPS3145<\/td>\nHPS3146<\/td>\nHPS3147<\/td>\nHPS3148<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Pulmonary hypertension<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pulmonary hypertension<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0209*<\/a><\/td>\nHPS0210*<\/a><\/td>\nHPS0211*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary pulmonary hypertension, heritable pulmonary arterial hypertension with unknown etiology<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1385<\/a><\/td>\nHPS1386<\/td>\nHPS1387<\/td>\nHPS1388<\/td>\nHPS1389<\/td>\nHPS1390<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3155<\/td>\nHPS3156<\/td>\nHPS3157<\/td>\nHPS3158<\/td>\nHPS3159<\/td>\nHPS3160<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary pulmonary\u00a0hypertension, idiopathic pulmonary arterial hypertension<\/a><\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1373<\/a><\/td>\nHPS1374<\/td>\nHPS1375<\/td>\nHPS1376<\/td>\nHPS1377<\/td>\nHPS1378<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Pulmonary veno-occlusive disease \/ pulmonary capillary hemangiomatosis<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pulmonary veno-occlusive disease \/ pulmonary capillary hemangiomatosis<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1484<\/td>\nHPS1485<\/td>\nHPS1486<\/td>\nHPS1487<\/td>\nHPS1488<\/td>\nHPS1489<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2290<\/td>\nHPS2291<\/td>\nHPS2292<\/td>\nHPS2293<\/td>\nHPS2294<\/td>\nHPS2295<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Idiopathic chronic pulmonary thromboembolism with pulmonary hypertension<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1538<\/td>\nHPS1539<\/td>\nHPS1540<\/td>\nHPS1541<\/td>\nHPS1542<\/td>\nHPS1543<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2202<\/td>\nHPS2203<\/td>\nHPS2204<\/td>\nHPS2205<\/td>\nHPS2206<\/td>\nHPS2207<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6. Lymphangioleiomyomatosis<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Lymphangioleiomyomatosis, sporadic LAM<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1502<\/td>\nHPS1503<\/td>\nHPS1504<\/td>\nHPS1505<\/td>\nHPS1506<\/td>\nHPS1507<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3290<\/td>\nHPS3291<\/td>\nHPS3292<\/td>\nHPS3293<\/td>\nHPS3294<\/td>\nHPS3295<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Lymphangioleiomyomatosis, TSC-LAM<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2114<\/a><\/td>\nHPS2115<\/a><\/td>\nHPS2116<\/a><\/td>\nHPS2117<\/td>\nHPS2118<\/td>\nHPS2119<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. Pulmonary alveolar proteinosis (PAP)<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pulmonary alveolar proteinosis (PAP), autoimmune<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2371<\/td>\nHPS2372<\/td>\nHPS2373<\/td>\nHPS2374<\/td>\nHPS2375<\/td>\nHPS2376<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Alveolar hypoventilation syndrome (AHS)<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Alveolar hypoventilation syndrome (AHS), mutation in PHOX2<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2413<\/td>\nHPS2414<\/td>\nHPS2415<\/td>\nHPS2416<\/td>\nHPS2417<\/td>\nHPS2418<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9. Congenital diaphragmatic hernia<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Congenital diaphragmatic hernia<\/a><\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2888<\/td>\nHPS2889<\/td>\nHPS2890<\/td>\nHPS2891<\/td>\nHPS2892<\/td>\nHPS2893<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Eye diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. \tRetinitis pigmentosa <\/a><\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Retinitis pigmentosa<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0061<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS0062<\/a><\/td>\nHPS0104<\/td>\nHPS0105<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n<\/td>\n<\/td>\nHPS0072<\/a><\/td>\nHPS0106<\/td>\nHPS0107<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\n<\/td>\n<\/td>\nHPS0073<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5<\/td>\n<\/td>\n<\/td>\nHPS0074<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6<\/td>\n<\/td>\n<\/td>\nHPS0075<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7<\/td>\n<\/td>\n<\/td>\nHPS0938<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8<\/td>\n<\/td>\n<\/td>\nHPS1075<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Macular degeneration<\/a><\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Age related Macular degeneration, retinal angiomatous proliferation<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1072<\/a><\/td>\nHPS1756<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS1757<\/td>\nHPS1758<\/td>\nHPS1759<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Best disease<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1012<\/a><\/td>\nHPS1760<\/td>\nHPS1761<\/td>\nHPS1762<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3.Leber Hereditary Optic Neuropathy<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Leber Hereditary Optic Neuropathy<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1071<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Leber Hereditary Optic Neuropathy, mtDNA G11778A<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1776<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n<\/td>\n<\/td>\nHPS1900<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4.Gelatinous drop-like corneal dystrophy<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Gelatinous drop-like corneal dystrophy<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS1013<\/a><\/td>\nHPS1903<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address. \uff0a In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available *Terms: In relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary. In relation to all iPS cell lines, commercial use is prohibited. In relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize. Update : 2020.11.27 Name of diseases Patient No. *Terms Approval For >HPS References Respiratory tract diseases 1. Sarcoidosis Sarcoidosis 1 \u25ce Unnecessary HPS1496 HPS1497 HPS1498 HPS1499 HPS1500 HPS1501 2 \u25ce Unnecessary HPS2090 HPS2091 HPS2092 HPS2093 HPS2094 HPS2095 2. Idiopathic interstitial pneumonia Idiopathic interstitial pneumonia, idiopathic pulmonary fibrosis 1 \u25ce Unnecessary HPS1324 2 \u25ce Unnecessary HPS1466 HPS1467 HPS1468 HPS1469 HPS1470 HPS1471 3 \u25ce Unnecessary HPS3143 […]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":10124,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-10160","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=10160"}],"version-history":[{"count":4,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10160\/revisions"}],"predecessor-version":[{"id":10405,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10160\/revisions\/10405"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10124"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=10160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}